
Mark A. Lewis, MD, explains when unexpected disease behavior in neuroendocrine tumors should prompt a specialist referral and how patients can still be treated close to home.
Frank A. Sinicrope, MD, medical oncologist, Departments of Gastroenterology and Hepatology and Oncology, Cancer Center, Mayo Clinic discusses a study on two adjuvant trials in patients with stage III colon cancer.
Sinicrope and his team conducted the study in order to look at the association of overall survival with colon cancers that have deficient DNA mismatch repair. Both large adjuvant trials were randomized, and they were conducted within the United States and Europe.
Frank A. Sinicrope, MD, medical oncologist, Departments of Gastroenterology and Hepatology and Oncology, Cancer Center, Mayo Clinic discusses a study on two adjuvant trials in patients with stage III colon cancer.






